AMERICAN JOURNAL OF EMERGENCY MEDICINE, cilt.51, ss.223-227, 2022 (SCI-Expanded, Scopus)
Objective: The absence of a specific biomarker for acute mesenteric ischemia diagnosis results in a delay in diagnosis and treatment, as well as a high mortality rate. The current research examined whether the proteins adropin, HIF-1 alpha, and apelin may be used to help in the early detection of acute mesenteric ischemia.